Globally, Radon—a naturally occurring radioactive gas—is the second leading cause of lung cancer after smoking. Despite this, radon remains a largely ...
One upcoming decision—on a perioperative PD-1 regimen for lung cancer—comes as the FDA considers an overhaul of trial designs in this treatment setting.